Changes of Intestinal Inflammatory Injury Induced by DSS in GC-C<sup>-/-</sup> Mice

Guili LIANG; Canmei LI; Chengfeng XING; Yunlong DONG; Juan WANG; Zi LEI; Yinglei MIAO; Danfeng LAN

doi:10.12259/j.issn.2095-610X.S20220712

Volume 43 Issue 7

Jul. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(7): 1-8

Guili LIANG, Canmei LI, Chengfeng XING, Yunlong DONG, Juan WANG, Zi LEI, Yinglei MIAO, Danfeng LAN. Changes of Intestinal Inflammatory Injury Induced by DSS in GC-C-/- Mice[J]. Journal of Kunming Medical University, 2022, 43(7): 1-8. doi: 10.12259/j.issn.2095-610X.S20220712

Citation:

Guili LIANG, Canmei LI, Chengfeng XING, Yunlong DONG, Juan WANG, Zi LEI, Yinglei MIAO, Danfeng LAN. Changes of Intestinal Inflammatory Injury Induced by DSS in GC-C^-/- Mice[J]. Journal of Kunming Medical University, 2022, 43(7): 1-8. doi: 10.12259/j.issn.2095-610X.S20220712

Citation:

PDF( 2067 KB)

Changes of Intestinal Inflammatory Injury Induced by DSS in GC-C^-/- Mice

doi: 10.12259/j.issn.2095-610X.S20220712

1.
Dept. of Gastroenterology，The 1st Affilited Hospital of Kunming Medical University，Yunnan Province Clinical Research Center for Digestive Diseases，Kunming Yunnan 650032
2.
Dept. of Oncology，Dali Bai Autonomous Prefecture People’s Hospital，Dali Yunnan 671000
3.
Dept. of Clinical Laboratory
4.
Dept. of Pathology，The 1st Affilited Hospital of Kunming Medical University，Kunming Yunnan 650032，China

Received Date: 2022-04-05
Available Online: 2022-07-01
Publish Date: 2022-07-14

Abstract

Abstract

Objective To investigate the role of guanylate cyclase C （GC-C） signaling pathway in the intestinal inflammatory injury of mice induced by sodium dextran sulfate （DSS）. Methods The colitis models were constructed using DSS in the GC-C gene knockout （GC-C^-/-） mice and wild-type （WT） mice. The mice were divided into the colitis groups which were given drinking 3% DSS solution for one week, and the control groups which were given normal diet. The expressions of GC-C mRNA and protein in colon tissues were detected by the methods of qRT-PCR and western blot. The inflammatory damage of colon tissues was observed by the HE staining and the histopathological score was performed by the light microscope. The levels of inflammatory factors （IL-8 and TNF-α） in the peripheral blood as well as intestinal mucus of mice were determined by ELISA. Results 1. Compared with the WT mice, the disease activity index （DAI） scores of the GC-C^-/- mice induced by DSS increased significantly （P < 0.05）, and the shortening of colon, intestinal thickening, hyperemia and edema were more obvious; 2. The inflammatory damage of colon tissues was more serious and the histopathological score was higher in the GC-C^-/-+DSS group than that of the WT+DSS group significantly （P < 0.05）; 3. The levels of IL-8 and TNF-αin the peripheral blood and intestinal mucus were higher in the GC-C^-/-+DSS group than that of the WT+DSS group significantly （P < 0.05, respectively）. Conclusions The intestinal inflammatory injury is more serious in the GC-C^-/- mice induced by chemical substances. GC-C signaling pathway may be involved in the occurrence and development of ulcerative colitis （UC）.
- Guanylate cyclase C,
- Gene knockout,
- Intestinal inflammation,
- Ulcerative colitis

FullText(HTML)

References(21)

References

[1]	Shah S C,Itzkowitz S H. Colorectal cancer in inflammatory bowel disease:mechanisms and management[J]. Gastroenterology,2022,162(3):715-730. doi: 10.1053/j.gastro.2021.10.035
[2]	Ng S C,Shi H Y,Hamidi N,et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century:a systematic review of population-based studies[J]. Lancet,2018,390(10114):2769-2778.
[3]	Benchimol E I,Bernstein C N,Bitton A,et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada:distributed network analysis of multiple population-based provincial health administrative databases[J]. Am J Gastroenterol,2017,112(7):1120-1134. doi: 10.1038/ajg.2017.97
[4]	Uranga J A,Castro M,Abalo R. Guanylate cyclase C:A current hot target,from physiology to pathology[J]. Curr Med Chem,2018,25(16):1879-1908.
[5]	Rappaport J A,Waldman S A. The guanylate cyclase C-cGMP signaling axis opposes intestinal epithelial injury and neoplasia[J]. Front Oncol,2018,8:299. doi: 10.3389/fonc.2018.00299
[6]	Xing C,Zhang T,Liu X,et al. Guanylin ligand protects the intestinal immune barrier by activating the guanylate cyclase-C signaling pathway[J]. Acta Histochem,2022,124(1):151811. doi: 10.1016/j.acthis.2021.151811
[7]	Lan D,Wen Y,Dong X,et al. The endogenous ligand for guanylate cyclase-C activation reliefs intestinal inflammation in the DSS colitis model[J]. Acta Biochim Pol,2020,67(3):333-340.
[8]	苗政,钱家鸣,李景南,等. 两种溃疡性结肠炎小鼠模型的构建及其炎症反应机制比较[J]. 协和医学杂志,2010,1(2):145-149.
[9]	Baumgart D C,Le Berre C. Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease[J]. N Engl J Med,2020,385(14):1302-1315.
[10]	Su H J,Chiu Y T,Chiu C T,et al. Inflammatory bowel disease and its treatment in 2018:Global and Taiwan residents status updates[J]. J Formos Med Assoc,2019,118(7):1083-1092.
[11]	Sasson A N,Ananthakrishnan A N,Raman M. Diet in Treatment of Inflammatory Bowel Diseases[J]. Clin Gastroenterol Hepatol,2021,19(3):425-435.
[12]	Camilleri M. Guanylate cyclase C agonists:emerging gastrointestinal therapies and actions[J]. Gastroenterology,2015,148(3):483-487. doi: 10.1053/j.gastro.2015.01.003
[13]	Lan D,Niu J,Miao J,et al. Expression of guanylate cyclase-C,guanylin,and uroguanylin is downregulated proportionally to the ulcerative colitis disease activity index[J]. Sci Rep,2016,6:25034. doi: 10.1038/srep25034
[14]	Wang Y J,Lan D F,Niu J K,et al. Guanylate cyclase-C signaling pathway regulates intestinal inflammatory injury and epithelial barrier function in Caco-2 cells[J]. Int J Clin Exp Pathol,2016,9(9):8858-8868.
[15]	Harmel-Laws E,Mann E A,Cohen M B,et al. Guanylate cyclase C deficiency causes severe inflammation in a murine model of spontaneous colitis[J]. PLoS One,2013,8(11):e79180. doi: 10.1371/journal.pone.0079180
[16]	Fiskerstrand T,Arshad N,Haukanes B I,et al. Familial diarrhea syndrome caused by an activating GUCY2C mutation[J]. N Engl J Med,2012,366(17):1586-1595. doi: 10.1056/NEJMoa1110132
[17]	Mishra V,Bose A,Kiran S,et al. Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C[J]. J Exp Med,2021,218(11):e20210479c. doi: 10.1084/jem.20210479
[18]	Steinbrecher K A,Harmel-Laws E,Garin-Laflam M P,et al. Murine guanylate cyclase C regulates colonic injury and inflammation[J]. J Immunol,2011,186(12):7205-7214. doi: 10.4049/jimmunol.1002469
[19]	Lin J E,Snook A E,Li P,et al. GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity[J]. PLoS One,2012,7(2):e31686. doi: 10.1371/journal.pone.0031686
[20]	Han X,Mann E,Gilbert S,et al. Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrier[J]. PLoS One,2011,6(1):e16139. doi: 10.1371/journal.pone.0016139
[21]	Li P, Lin J E, Chervoneva I, et al. Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine. Am J Pathol, 2007, 171（6）: 1847-1858.

Relative Articles(20)

Relative Articles

[1]	Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2025, 46(4): 1-9.
[2]	Bo LI, Yang SUN, Yinglei MIAO. Intestinal Microecological Changes and Therapeutics in Inflammatory Bowel Disease. Journal of Kunming Medical University, 2024, 45(4): 1-8. doi: 10.12259/j.issn.2095-610X.S20240401
[3]	Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2024, 45(10): 36-44. doi: 10.12259/j.issn.2095-610X.S20241006
[4]	Meizi RAO, Xinyi JIANG, Jiarong MIAO. Analysis of Risk Factors for Co-Infection of Ulcerative Colitis with Epstein-barr Virus and Cytomegalovirus. Journal of Kunming Medical University, 2024, 45(11): 1-8.
[5]	Chunling LI, Linghua LI, Xu HAN, Jie YANG, Heng ZHANG. Clinical Observation of Treating Ulcerative Colitis with Acupuncture at Front Mu Points Combined with Oral Mesalazine. Journal of Kunming Medical University, 2024, 45(3): 72-78. doi: 10.12259/j.issn.2095-610X.S20240311
[6]	Dan LI, Xulian WAN, Lvyu LI, Yu YUN, Guangyun LUO, Weibing LIU, Gongfu LIN, Ning LI, Yongkun LI, Weigang DUAN. Intestinal Flora in Uricase-Deficient Rats. Journal of Kunming Medical University, 2023, 44(2): 27-32. doi: 10.12259/j.issn.2095-610X.S20230205
[7]	Jing WANG, Hongying MI, Yi ZHANG, Li LI, Jianhua YU, Liqiao LIU, Qingyu LIU, Liwei WANG. Pyrotosis Participates in the Pathogenesis of Necrotizing Enterocolitis in Early Offspring Rats. Journal of Kunming Medical University, 2023, 44(1): 25-30. doi: 10.12259/j.issn.2095-610X.S20230124
[8]	Luqiong LIU, Tong CHEN, Yongjin ZHANG, Zhenrong XIE, Chenglu HE, Yongkun HUANG. Butyric Acid Protects Intestinal Epithelial Barrier from Injury Induced by TNFα. Journal of Kunming Medical University, 2023, 44(10): 10-17. doi: 10.12259/j.issn.2095-610X.S20231021
[9]	Xiaolin LIU, Xiaocui CHEN, Yang SUN, Minli LI, Yinglei MIAO. Clinical Efficacy and Safety Evaluation of Fecal Bacteria Transplantation by Different Ways on Ulcerative Colitis. Journal of Kunming Medical University, 2022, 43(6): 46-51. doi: 10.12259/j.issn.2095-610X.S20220612
[10]	Xing LIU, Hai-wen LI, Hong-li HUANG, Lin-jun SHEN, Le ZHANG, Xiang-fang LIU, Wen-lin ZHANG, Lu WANG. Effects of Probiotics Enhanced Enteral Nutrition on Gastrointestinal Function and Cytokines in Patients with Severe Acute Pancreatitis. Journal of Kunming Medical University, 2021, 42(11): 81-86. doi: 10.12259/j.issn.2095-610X.S20211116
[11]	Jing WANG, Lian-fang TANG, Mei-qun GU, Xiao-yan XU, Jian-hua YU, Shan HE, Zi-wei LI, Kai BI, Li-qiao LIU, Qiong ZHAO, Hong-ying MI. Risk Factors and Early Clinical Characteristics of Neonatal Necrotizing Enterocolitis. Journal of Kunming Medical University, 2021, 42(11): 99-104. doi: 10.12259/j.issn.2095-610X.S20211118
[12]	Zhang Nan , Hu Xin Yu , Dong Xian Xiang , Duan Wei Gang , Yun Yu . . Journal of Kunming Medical University, 2019, 40(06): 129-134.
[13]	Wang Rui Tao , Jia Qing An , Mou Yi Ping , Geng Zhi Min , Liu Chang . The Clinical Evaluation of Danning Tablets on Regulating Gut Flora Displacement to Eliminate Biliary Inflammation and Prevent Gallstone Formation. Journal of Kunming Medical University, 2018, 39(01): 109-112.
[14]	Tian Yun Fen , Li Li , Mi Hong Ying , Huang Fu Chun Rong , He Shan , Xu Xiao Yan , Cao Yong Jiu . The Clinical Analysis of Necrotizing Enterocolitis. Journal of Kunming Medical University, 2018, 39(02): 60-64.
[15]	Zhang An Xing , Wu Jing , Sun Yang , Miao Ying Lei . . Journal of Kunming Medical University, 2018, 39(09): 128-132.
[16]	Zhou Xiao Nan , Song Xue Lan , Yang Yuan , Ma Chen Jing , He Fang Yan . Advances and Applications in Gene Silencing. Journal of Kunming Medical University, 2018, 39(01): 131-135.
[17]	Chen Xiao Hong . Influence of Continuous Nursing Intervention on Psychological Quality and Medication Compliance in Ulcerative Colitis Patients after Discharge. Journal of Kunming Medical University,
[18]	Meng Jun . . Journal of Kunming Medical University,
[19]	Li Hong Li . . Journal of Kunming Medical University,
[20]	Ai Jia . . Journal of Kunming Medical University,